| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | CN1898262A Il-7 fusion proteins |
| 01/17/2007 | CN1896245A Production of gene recombinant fusion protein K1-EN |
| 01/17/2007 | CN1896108A Preparation of specific anticoagulation matter and its use |
| 01/17/2007 | CN1896107A Cecropin A-magainin hybrid gene engineering bactericidal peptide |
| 01/17/2007 | CN1896106A Preparation of human plasma protein fused long-effective interferon |
| 01/17/2007 | CN1896105A Compounds and methods of early diagnosis of cervical cancer and genital condyloma with hpv, chsp60 tumor suppressor h-ras, k-ras and pten derived peptides modified |
| 01/17/2007 | CN1896104A Fused protein for cell inhibitory factor and albumin |
| 01/17/2007 | CN1896099A Zinc finger binding domains for gnn |
| 01/16/2007 | US7163817 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation |
| 01/16/2007 | CA2232240C Peptide for inhibiting growth of smooth muscle cells |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/11/2007 | WO2006082313A3 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 01/11/2007 | WO2006074390A3 Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides |
| 01/11/2007 | US20070010661 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070009955 Secreted polypeptide species associated with cardiovascular disorders |
| 01/11/2007 | US20070009921 Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/10/2007 | EP1741718A2 Expression of lipoproteins |
| 01/10/2007 | EP1485129B1 Nanostructures containing pilin protein |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1339745B1 Immunotherapeutic methods and molecules |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | CN1893980A Novel GLP-1 analogues linked to albumin-like agents |
| 01/10/2007 | CN1891718A Fusion immunotoxin ML-L-SEC2 and gene and its preparation |
| 01/10/2007 | CN1294258C Method for separating antibiotic peptide and separated antibiotic peptide |
| 01/10/2007 | CN1294149C Gene engineering recombinant protein capable of specifically killing tumor cell |
| 01/10/2007 | CN1294148C Single-stranded cyctic trispecific antibody |
| 01/10/2007 | CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 01/09/2007 | US7160726 Compositions comprising conditioned cell culture media and uses thereof |
| 01/09/2007 | CA2236751C Method for producing a correctly folded, biological active recombinant protein |
| 01/09/2007 | CA2141454C Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/04/2007 | US20070006343 Modified oleosins |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 01/04/2007 | US20070003567 Composition and methods for enhancing immunogenecity of antigens |
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | DE10328775B4 In vivo-Testsystem zum Nachweis von HIV-Proteaseaktivität In vivo test system for the detection of HIV protease activity |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1737963A1 Use of a gene coding for the c4bp protein beta chain for producing recombinant dimeric proteins |
| 01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0787139B1 Synthetic peptides and vaccines comprising same |
| 01/03/2007 | EP0669929B1 Elk ligand, a cytokine |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1887829A Synthesis process of 18F lebeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1293098C Concatameric immunoadhesion |
| 01/02/2007 | US7157566 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis |
| 01/02/2007 | US7157238 Identifying micrometastsized tissue/masses using double immunoglobulin labeling; immunodiagnostics and cancer detection |
| 01/02/2007 | US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1. |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 12/28/2006 | WO2006136084A1 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | US20060293230 Expression and secretion of icIL-1 receptor antagonist type II |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
| 12/28/2006 | US20060292554 Major coat protein variants for C-terminal and bi-terminal display |
| 12/28/2006 | US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception |
| 12/28/2006 | US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
| 12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
| 12/28/2006 | US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 12/28/2006 | US20060292118 Hollow nanoparticles of protein and drug using the same |
| 12/28/2006 | US20060292116 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 12/28/2006 | DE102004032888B4 Rekombinante ScV-Partikel, ihre kodierenden Nukleinsäuren und ihre Verwendungen Recombinant SCV particle, its encoding nucleic acids and their uses |
| 12/27/2006 | EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation |
| 12/27/2006 | EP1736545A2 Soluble zcytor 11 cytokine receptors |
| 12/27/2006 | EP1736484A1 An gene enginf; ering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody |
| 12/27/2006 | EP1735350A2 Anti-cea scfv - beta-lactamase constructs (cab molecules) in adept |
| 12/27/2006 | EP1539964B1 Collectin-complement activating protein chimeras |
| 12/27/2006 | EP1418180B1 Chimeric chains that code for proteins that induce effects directed against viruses |
| 12/27/2006 | EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection |
| 12/27/2006 | CN1884555A Method for preparing phase granule for displaying polypeptide |
| 12/27/2006 | CN1884553A hMCP-hRANTES-pcDNA3.1 recombinant plasmid construction and expression method |
| 12/27/2006 | CN1884520A Preparation method of fusion protein of human interleukin-2 and human serum albumin and product |
| 12/27/2006 | CN1884303A SARS-CoV virus structural protein infusion protein and its high yield expression and purification and uses |
| 12/27/2006 | CN1884302A Staphylococcus aureus fusion protein of fibronectin and bindin, its preparation method and uses |
| 12/27/2006 | CN1884301A Targeted function superantigen and its preparation method and use |
| 12/27/2006 | CN1884300A Targeted function anti-liver cancer superantigen and its preparation method and use |
| 12/27/2006 | CN1884299A Staphylococcus aureus surface protein fusion protein, its preparation method and uses |
| 12/27/2006 | CN1292002C Arginine deacylase fusion protein, method for preparation and application |
| 12/26/2006 | US7153949 Nucleic acid encoding poly-zinc finger proteins with improved linkers |
| 12/26/2006 | US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases |
| 12/26/2006 | US7153662 Inflammation-specific peptides and the uses thereof |
| 12/21/2006 | WO2006135385A2 Antagonizing interleukin-21 receptor activity |
| 12/21/2006 | WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
| 12/21/2006 | US20060287513 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/21/2006 | US20060287502 C3b/C4b complement receptor-like molecules and uses thereof |
| 12/21/2006 | US20060287432 Peptide purification by means of metal ion affinity chromatography |
| 12/21/2006 | CA2612151A1 Agents and methods based on the use of the eda domain of fibronectin |
| 12/21/2006 | CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof |
| 12/21/2006 | CA2574848A1 Antagonizing interleukin-21 receptor activity |
| 12/20/2006 | EP1734051A2 Composition and methods for the diagnosis of tumours |
| 12/20/2006 | EP1732947A2 Growth factor binding constructs materials and methods |
| 12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |